Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 91
Filtrar
1.
Phys Rev E ; 107(5-1): 054303, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-37329018

RESUMEN

It is well known that tree-based theories can describe the properties of undirected clustered networks with extremely accurate results [S. Melnik et al., Phys. Rev. E 83, 036112 (2011)10.1103/PhysRevE.83.036112]. It is reasonable to suggest that a motif-based theory would be superior to a tree one, since additional neighbor correlations are encapsulated in the motif structure. In this paper, we examine bond percolation on random and real world networks using belief propagation in conjunction with edge-disjoint motif covers. We derive exact message passing expressions for cliques and chordless cycles of finite size. Our theoretical model gives good agreement with Monte Carlo simulation and offers a simple, yet substantial improvement on traditional message passing, showing that this approach is suitable to study the properties of random and empirical networks.


Asunto(s)
Algoritmos , Modelos Teóricos , Simulación por Computador , Método de Montecarlo
2.
Phys Rev E ; 106(1-1): 014304, 2022 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-35974532

RESUMEN

In this paper we examine the emergent structures of random networks that have undergone bond percolation an arbitrary, but finite, number of times. We define two types of sequential branching processes: a competitive branching process, in which each iteration performs bond percolation on the residual graph (RG) resulting from previous generations, and a collaborative branching process, where percolation is performed on the giant connected component (GCC) instead. We investigate the behavior of these models, including the expected size of the GCC for a given generation, the critical percolation probability, and other topological properties of the resulting graph structures using the analytically exact method of generating functions. We explore this model for Erdos-Renyi and scale-free random graphs. This model can be interpreted as a seasonal N-strain model of disease spreading.

3.
Phys Rev E ; 105(4-1): 044314, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35590545

RESUMEN

Correlations among the degrees of vertices in random graphs often occur when clustering is present. In this paper we define a joint-degree correlation function for vertices in the giant component of clustered configuration model networks which are composed of clique subgraphs. We use this model to investigate, in detail, the organization among nearest-neighbor subgraphs for random graphs as a function of subgraph topology as well as clustering. We find an expression for the average joint degree of a neighbor in the giant component at the critical point for these networks. Finally, we introduce a novel edge-disjoint clique decomposition algorithm and investigate the correlations between the subgraphs of empirical networks.

4.
Can J Public Health ; 113(5): 776-785, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-35616872

RESUMEN

OBJECTIVE: The aim of this study was to explore the acceptability of bacterial STI vaccines among young HPV-vaccinated Canadian women to inform future vaccine program implementation. METHODS: A 20-item cross-sectional questionnaire was administered from June 2019 to June 2020 to HPV-vaccinated participants of the pan-Canadian QUEST cohort. Multivariable logistic regression models assessed interest in chlamydia, syphilis, and gonorrhea vaccines using a priori variables and factors significant in bivariate analysis. RESULTS: Of the 1092 respondents analyzed, 82% indicated interest in receiving one or more future STI vaccines. Respondents had a median age of 19.6 years (range 16.9-23.4), and 75% of respondents identified as white/European descent. In adjusted analyses, intent to engage in positive health behaviours was associated with vaccine interest for syphilis (OR = 5.76, 95% CI 4.03-8.27), chlamydia (OR = 5.27, 95% CI 3.66-7.63), and gonorrhea (OR = 5.96, 95% CI 4.15-8.60). Willingness to pay for an STI vaccine was also associated with vaccine interest for syphilis (OR = 2.02, 95% CI 1.29-3.19), chlamydia (OR = 2.41, 95% CI 1.50-3.90), and gonorrhea (OR = 2.29, 95% CI 1.44-3.63). Ever having sexual intercourse and identifying as LGBTQ were significantly associated with vaccine interest for all infections, while age and ever being immunosuppressed were not significant in any adjusted models. CONCLUSION: Findings indicate over 80% of participants in a cohort of young HPV-vaccinated Canadian women are interested in receiving future bacterial STI vaccines. Further exploration of STI vaccine acceptability among diverse populations is required to inform future bacterial STI vaccine program implementation.


RéSUMé: OBJECTIF: Cette étude visait à explorer l'acceptabilité des vaccins contre les ITS bactériennes chez les jeunes Canadiennes vaccinées contre le VPH pour éclairer la mise en œuvre de futurs programmes de vaccination. MéTHODE: Un questionnaire transversal de 20 questions a été administré entre juin 2019 et juin 2020 aux participantes de la cohorte QUEST pancanadienne ayant été vaccinées contre le VPH. Des modèles de régression logistique multivariée ont permis d'analyser l'intérêt pour les vaccins contre la chlamydia, la syphilis et la gonorrhée à l'aide de variables a priori et des facteurs significatifs dans l'analyse bivariée. RéSULTATS: Sur les 1 092 répondantes analysées, 82 % ont manifesté l'intérêt de recevoir un ou plusieurs futurs vaccins contre les ITS. L'âge médian des répondantes était de 19,6 ans (intervalle 16,9­23,4), et 75 % s'identifiaient comme étant blanches/d'ascendance européenne. Dans les analyses ajustées, l'intention de s'adonner à des comportements de santé positifs était associée à l'intérêt pour les vaccins contre la syphilis (RC = 5,76, IC de 95 % 4,03­8,27), la chlamydia (RC = 5,27, IC de 95 % 3,66­7,63) et la gonorrhée (RC = 5,96, IC de 95 % 4,15­8,60). La volonté de payer pour un vaccin contre les ITS était aussi associée à l'intérêt pour les vaccins contre la syphilis (RC = 2,02, IC de 95 % 1,29­3,19), la chlamydia (RC = 2,41, IC de 95 % 1,50­3,90) et la gonorrhée (RC = 2,29, IC de 95 % 1,44­3,63). Le fait d'avoir déjà eu des rapports sexuels et le fait de s'identifier comme une personne LGBTQ présentaient une corrélation significative avec l'intérêt pour les vaccins contre toutes les infections, mais l'âge et le fait d'avoir déjà subi un traitement immunodépresseur n'étaient des facteurs significatifs dans aucun des modèles ajustés. CONCLUSION: Selon nos constatations, plus de 80 % des participantes d'une cohorte de jeunes Canadiennes vaccinées contre les VPH sont intéressées à recevoir de futurs vaccins contre les ITS bactériennes. Une exploration plus poussée de l'acceptabilité des vaccins contre les ITS dans des populations à forte mixité est nécessaire pour éclairer la mise en œuvre de futurs programmes de vaccination contre les ITS bactériennes.


Asunto(s)
Gonorrea , Infecciones por VIH , Infecciones por Papillomavirus , Vacunas contra Papillomavirus , Enfermedades de Transmisión Sexual , Sífilis , Adolescente , Adulto , Canadá/epidemiología , Estudios Transversales , Femenino , Humanos , Intención , Infecciones por Papillomavirus/epidemiología , Infecciones por Papillomavirus/prevención & control , Vacunas contra Papillomavirus/uso terapéutico , Conducta Sexual , Enfermedades de Transmisión Sexual/epidemiología , Enfermedades de Transmisión Sexual/prevención & control , Adulto Joven
5.
Microbiol Spectr ; 9(3): e0078321, 2021 12 22.
Artículo en Inglés | MEDLINE | ID: mdl-34730438

RESUMEN

Lower levels of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in the nasal epithelium of children may be related to a lower incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, compared to adults. However, no direct evidence is available to support this hypothesis. In this study, we compared the transcript levels of ACE2 and TMPRSS2 in nasopharyngeal swab samples (n = 234) from children and adult family members within SARS-CoV-2-exposed families and assessed the association with SARS-CoV-2 infection status. Transcript levels for ACE2, but not TMPRSS2, were higher in adults than in children (n = 129 adults and 105 children; P < 0.05). The expression of the two genes was not significantly different between SARS-CoV-2 positive and SARS-CoV-2 negative patients within the same age groups. However, in families with one or more SARS-CoV-2 positive adult family members, expression of both genes was significantly higher in SARS-CoV-2 positive children than in SARS-CoV-2 negative children (P < 0.05). By multivariate analysis, ACE2 expression adjusted for age and sex was significantly associated with SARS-CoV-2 infection in the overall population (odds ratio [OR], 1.112 [95% confidence interval [CI], 1.012 to 1.229]; P < 0.05). The degree of this association was higher (OR, 1.172 [95% CI, 1.034 to 1.347]; P < 0.05) in the subgroup of families with only SARS-CoV-2 positive adult family members. Our results suggest that children with lower levels of nasal ACE2 and TMPRSS2 are more likely to remain SARS-CoV-2 negative despite being exposed to a SARS-CoV-2 positive adult family member. IMPORTANCE ACE2 and TMPRSS2 are well established in the literature as SARS-CoV-2 entry factors. Recent data suggest that lower levels of nasal ACE2 in children may be associated with their lower incidence of coronavirus disease 2019 (COVID-19). In this study, using data from nasopharyngeal swab specimens from adult and pediatric members of families in which one or more members of the family had laboratory-confirmed SARS-CoV-2 infection, we show that children with lower levels of ACE2 and TMPRSS2 are more likely to remain SARS-CoV-2 negative despite being exposed to a SARS-CoV-2 positive adult family member. These results provide new insights into the roles of nasopharyngeal ACE2 and TMPRSS2 in acquiring SARS-CoV-2 infection, and they show that the differential expression of these genes in adults versus children may contribute to differential rates of SARS-CoV-2 infection in these populations.


Asunto(s)
Enzima Convertidora de Angiotensina 2/metabolismo , COVID-19/metabolismo , Nasofaringe/metabolismo , SARS-CoV-2 , Serina Proteasas/metabolismo , Adulto , Enzima Convertidora de Angiotensina 2/genética , Niño , Preescolar , Femenino , Expresión Génica , Humanos , Lactante , Masculino , Nasofaringe/virología , Serina Endopeptidasas/genética , Serina Endopeptidasas/metabolismo , Manejo de Especímenes
6.
Phys Rev E ; 104(2-1): 024304, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34525512

RESUMEN

We present exact solutions for the size of the giant connected component of complex networks composed of cliques following bond percolation. We use our theoretical result to find the location of the percolation threshold of the model, providing analytical solutions where possible. We expect the results derived here to be useful to a wide variety of applications including graph theory, epidemiology, percolation, and lattice gas models, as well as fragmentation theory. We also examine the Erdos-Gallai theorem as a necessary condition on the graphicality of configuration model networks comprising clique subgraphs.

7.
Phys Rev E ; 104(2-1): 024303, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34525561

RESUMEN

In this paper we introduce a description of the equilibrium state of a bond percolation process on random graphs using the exact method of generating functions. This allows us to find the expected size of the giant connected component (GCC) of two sequential bond percolation processes in which the bond occupancy probability of the second process is modulated (increased or decreased) by a node being inside or outside of the GCC created by the first process. In the context of epidemic spreading this amounts to both an antagonistic partial immunity and a synergistic partial coinfection interaction between the two sequential diseases. We examine configuration model networks with tunable clustering. We find that the emergent evolutionary behavior of the second strain is highly dependent on the details of the coupling between the strains. Contact clustering generally reduces the outbreak size of the second strain relative to unclustered topologies; however, positive assortativity induced by clustered contacts inverts this conclusion for highly transmissible disease dynamics.

8.
Phys Rev E ; 103(6-1): 062308, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-34271633

RESUMEN

Networks provide a mathematically rich framework to represent social contacts sufficient for the transmission of disease. Social networks are often highly clustered and fail to be locally treelike. In this paper, we study the effects of clustering on the spread of sequential strains of a pathogen using the generating function formulation under a complete cross-immunity coupling, deriving conditions for the threshold of coexistence of the second strain. We show that clustering reduces the coexistence threshold of the second strain and its outbreak size in Poisson networks, while exhibiting the opposite effects on uniform-degree models. We conclude that clustering within a population must increase the ability of the second wave of an epidemic to spread over a network. We apply our model to the study of multilayer clustered networks and observe the fracturing of the residual graph at two distinct transmissibilities.

9.
Hum Vaccin Immunother ; 17(10): 3554-3561, 2021 10 03.
Artículo en Inglés | MEDLINE | ID: mdl-34187301

RESUMEN

Protection after human papillomavirus (HPV) vaccination can be maximized by optimizing vaccination schedules. We systematically reviewed immunogenicity and effectiveness of HPV vaccines administered 6 months apart compared with longer intervals. Seroconversion to vaccine-type HPV was non-inferior for 12- compared with 6-month intervals, but inconclusive for comparison of 36-96 months with 6 months. A 12-month interval showed non-inferior (margin 0.5) vaccine-type HPV antibody responses compared with a 6-month interval. Compared to 6 months, an interval of 36-96 months resulted in non-inferior antibody responses for HPV6 and high-risk types HPV16 and 18, but did not lead to a non-inferior antibody response for HPV11 (GMR 0.63, 95% CI:0.41-0.97). Data on the effectiveness of extended two-dose schedules were limited. Our findings indicate that HPV immunization programs could adopt a 12-month interval instead of 6 months for increased flexibility without compromising immunogenicity. Further evaluation to confirm the immunogenicity and effectiveness of intervals beyond 12 months is warranted.


Asunto(s)
Infecciones por Papillomavirus , Vacunas contra Papillomavirus , Anticuerpos Antivirales , Papillomavirus Humano 16 , Papillomavirus Humano 18 , Humanos , Esquemas de Inmunización , Infecciones por Papillomavirus/prevención & control
10.
Phys Rev E ; 103(4-1): 042307, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-34005956

RESUMEN

Coinfection is the process by which a host that is infected with a pathogen becomes infected by a second pathogen at a later point in time. An immunosuppressant host response to a primary disease can facilitate spreading of a subsequent emergent pathogen among the population. Social contact patterns within the substrate populace can be modeled using complex networks and it has been shown that contact patterns vastly influence the emergent disease dynamics. In this paper, we consider the effect of contact clustering on the coinfection dynamics of two pathogens spreading over a network. We use the generating function formulation to describe the expected outbreak sizes of each pathogen and numerically study the threshold criteria that permit the coexistence of each strain among the network. We find that the effects of clustering on the levels of coinfection are governed by the details of the contact topology.

11.
Int J Cancer ; 149(1): 191-199, 2021 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-33586169

RESUMEN

Since 2008, girls in British Columbia (BC), Canada, have been offered HPV vaccination through a school-based, publicly funded immunization program. The oldest birth cohort eligible for the vaccination program was born in 1994 and uptake is on average 63%. To evaluate the impact of the HPV vaccine in BC, ecological trends in cervical intraepithelial neoplasia (CIN) rates were assessed in young women before and after the implementation of the HPV vaccination program. Information on all Pap smears and histopathological abnormalities, in calendar years 2004-2017 in women 16-28 years of age in BC were obtained from the population-based BC Cancer Cervix Screening Program database. Rates of CIN 2 and 3 were calculated as the number of cases divided by the number of cytology specimens for that period. Rate ratios (RR) were calculated by negative binomial piecewise regression. Age-centered incidence rates of CIN 2 and 3 in BC declined significantly among women 16-23 years of age after HPV vaccine introduction compared to before vaccine introduction. The overall reduction postvaccination for CIN2 and 3 in women 16-23 years was respectively 62% (95% CI 54-68%) and 65% (95% CI 58-71%). Age-specific rates for CIN2 significantly declined for those 18-22 years of age and for those 19, 20 and 23 years of age for CIN3. Among women 24-28 years of age no decline in CIN2 and 3 rate over time was observed. The observed reduction in CIN 2 and 3 rates since the introduction of the school-based HPV vaccine program might illustrate the population impact of the BC provincial school-based HPV vaccination program.


Asunto(s)
Programas de Inmunización/métodos , Papillomaviridae/efectos de los fármacos , Infecciones por Papillomavirus/prevención & control , Vacunas contra Papillomavirus/administración & dosificación , Displasia del Cuello del Útero/prevención & control , Neoplasias del Cuello Uterino/prevención & control , Vacunación/estadística & datos numéricos , Adolescente , Adulto , Colombia Británica/epidemiología , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Papillomaviridae/inmunología , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/virología , Pronóstico , Instituciones Académicas , Neoplasias del Cuello Uterino/epidemiología , Neoplasias del Cuello Uterino/virología , Frotis Vaginal/métodos , Adulto Joven , Displasia del Cuello del Útero/epidemiología , Displasia del Cuello del Útero/virología
12.
Phys Rev E ; 103(1-1): 012313, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33601539

RESUMEN

Percolation theory can be used to describe the structural properties of complex networks using the generating function formulation. This mapping assumes that the network is locally treelike and does not contain short-range loops between neighbors. In this paper we use the generating function formulation to examine clustered networks that contain simple cycles and cliques of any order. We use the natural generalization to the Molloy-Reed criterion for these networks to describe their critical properties and derive an approximate analytical description of the size of the giant component, providing solutions for Poisson and power-law networks. We find that networks comprising larger simple cycles behave increasingly more treelike. Conversely, clustering composed of larger cliques increasingly deviate from the treelike solution, although the behavior is strongly dependent on the degree-assortativity.

13.
Phys Rev E ; 103(1-1): 012309, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33601615

RESUMEN

The structure of many real networks is not locally treelike and, hence, network analysis fails to characterize their bond percolation properties. In a recent paper [P. Mann, V. A. Smith, J. B. O. Mitchell, and S. Dobson, arXiv:2006.06744], we developed analytical solutions to the percolation properties of random networks with homogeneous clustering (clusters whose nodes are degree equivalent). In this paper, we extend this model to investigate networks that contain clusters whose nodes are not degree equivalent, including multilayer networks. Through numerical examples, we show how this method can be used to investigate the properties of random complex networks with arbitrary clustering, extending the applicability of the configuration model and generating function formulation.

14.
Open Forum Infect Dis ; 8(1): ofaa579, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33447640

RESUMEN

Peritoneal dialysis (PD)-associated peritonitis constitutes a major complication associated with the procedure. PD-associated peritonitis caused by nontuberculous mycobacteria, usually as a result of an infection related to the PD catheter, has been reported in adults and is associated with significant complications and poor outcome. The management of PD-associated peritonitis caused by Mycobacterium abscessus is particularly challenging because this species is resistant to many antimicrobials commonly used to treat mycobacterial species. We present here the second reported case of PD-associated peritonitis caused by M. abscessus in children. Our patient was a 9-year-old boy with end-stage renal disease (ESRD) who presented with suspected peritonitis, and his PD fluid cultures eventually grew M. abscessus. The patient received a 3-week course of triple therapy with clarithromycin, amikacin, and meropenem in addition to PD catheter removal. The infection completely resolved even though a susceptibility report at the end of treatment revealed that the isolate was resistant to clarithromycin and had decreased susceptibility to carbapenems. Our observations suggest that PD catheter removal is important in PD-associated peritonitis caused by M. abscessus in children and that more studies are needed to define the optimal length of treatment.

15.
Pediatrics ; 147(1)2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33386332

RESUMEN

BACKGROUND AND OBJECTIVES: Human papillomavirus (HPV) antibody responses to the 9-valent human papillomavirus (9vHPV) vaccine among girls and boys (aged 9-14 years) receiving 2-dose regimens (months 0, 6 or 0, 12) were noninferior to a 3-dose regimen (months 0, 2, 6) in young women (aged 16-26 years) 4 weeks after last vaccination in an international, randomized, open-label trial (NCT01984697). We assessed response durability through month 36. METHODS: Girls received 2 (months 0 and 6 [0, 6]: n = 301; months 0 and 12 [0, 12]: n = 151) or 3 doses (months 0,2, and 6 [0, 2, 6]: n = 301); boys received 2 doses ([0, 6]: n = 301; [0, 12]: n = 150); and young women received 3 doses ([0, 2, 6]: n = 314) of 9vHPV vaccine. Anti-HPV geometric mean titers (GMTs) were assessed by competitive Luminex immunoassay (cLIA) and immunoglobulin G-Luminex immunoassay (IgG-LIA) through month 36. RESULTS: Anti-HPV GMTs were highest 1 month after the last 9vHPV vaccine regimen dose, decreased sharply during the subsequent 12 months, and then decreased more slowly. GMTs 2 to 2.5 years after the last regimen dose in girls and boys given 2 doses were generally similar to or greater than GMTs in young women given 3 doses. Across HPV types, most boys and girls who received 2 doses (cLIA: 81%-100%; IgG-LIA: 91%-100%) and young women who received 3 doses (cLIA: 78%-98%; IgG-LIA: 91%-100%) remained seropositive 2 to 2.5 years after the last regimen dose. CONCLUSIONS: Antibody responses persisted through 2 to 2.5 years after the last dose of a 2-dose 9vHPV vaccine regimen in girls and boys. In girls and boys, antibody responses generated by 2 doses administered 6 to 12 months apart may be sufficient to induce high-level protective efficacy through at least 2 years after the second dose.


Asunto(s)
Alphapapillomavirus/inmunología , Anticuerpos Antivirales/sangre , Vacunas contra Papillomavirus/administración & dosificación , Adolescente , Adulto , Biomarcadores/sangre , Niño , Relación Dosis-Respuesta Inmunológica , Femenino , Estudios de Seguimiento , Humanos , Masculino , Vacunas contra Papillomavirus/inmunología , Adulto Joven
16.
J Theor Biol ; 506: 110381, 2020 12 07.
Artículo en Inglés | MEDLINE | ID: mdl-32771534

RESUMEN

Progress in shortening the duration of tuberculosis (TB) treatment is hampered by the lack of a predictive model that accurately reflects the diverse environment within the lung. This is important as TB has been shown to produce distinct localisations to different areas of the lung during different disease stages, with the environmental heterogeneity within the lung of factors such as air ventilation, blood perfusion and oxygen tension believed to contribute to the apical localisation witnessed during the post-primary form of the disease. Building upon our previous model of environmental lung heterogeneity, we present a networked metapopulation model that simulates TB across the whole lung, incorporating these notions of environmental heterogeneity across the whole TB life-cycle to show how different stages of the disease are influenced by different environmental and immunological factors. The alveolar tissue in the lung is divided into distinct patches, with each patch representing a portion of the total tissue and containing environmental attributes that reflect the internal conditions at that location. We include populations of bacteria and immune cells in various states, and events are included which determine how the members of the model interact with each other and the environment. By allowing some of these events to be dependent on environmental attributes, we create a set of heterogeneous dynamics, whereby the location of the tissue within the lung determines the disease pathological events that occur there. Our results show that the environmental heterogeneity within the lung is a plausible driving force behind the apical localisation during post-primary disease. After initial infection, bacterial levels will grow in the initial infection location at the base of the lung until an adaptive immune response is initiated. During this period, bacteria are able to disseminate and create new lesions throughout the lung. During the latent stage, the lesions that are situated towards the apex are the largest in size, and once a post-primary immune-suppressing event occurs, it is the uppermost lesions that reach the highest levels of bacterial proliferation. Our sensitivity analysis also shows that it is the differential in blood perfusion, causing reduced immune activity towards the apex, which has the biggest influence of disease outputs.


Asunto(s)
Mycobacterium tuberculosis , Tuberculosis , Humanos , Pulmón
17.
BMC Infect Dis ; 20(1): 237, 2020 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-32192451

RESUMEN

BACKGROUND: Infections with multidrug-resistant organisms (MDRO) pose a serious threat to patients with dysregulated immunity such as in hemophagocytic lymphohistiocytosis (HLH), but such infections have rarely been comprehensively characterized. Here, we present a fatal case of HLH secondary to cytomegalovirus (CMV) infection complicated by both anti-viral drug resistance and sepsis from multiple MDROs including pandrug-resistant superbug bacteria. CASE PRESENTATION: A previously healthy, six-year-old boy presented with a 45-day history of fever prior to a diagnosis of hemophagocytic lymphohistiocytosis and hemorrhagic colitis, both associated with CMV. On hospital admission, the patient was found to be colonized with multiple, multidrug-resistant (MDR) bacteria including vancomycin-resistant enterococci (VRE) and carbapenamase-producing organisms (CPO). He eventually developed respiratory, urine and bloodstream infections with highly drug-resistant, including pandrug-resistant bacteria, which could not be controlled by antibiotic treatment. Antiviral therapy also failed to contain his CMV infection and the patient succumbed to overwhelming bacterial and viral infection. Whole genome sequencing (WGS) of the MDR bacteria and metagenomic analysis of his blood sample revealed an unusual accumulation of a wide range of antimicrobial resistance mechanisms in a single patient, including antiviral resistance to ganciclovir, and resistance mechanisms to all currently available antibiotics. CONCLUSIONS: The case highlights both the risk of acquiring MDR superbugs and the severity of these infections in HLH patients.


Asunto(s)
Infecciones por Citomegalovirus/complicaciones , Citomegalovirus/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/genética , Farmacorresistencia Viral Múltiple , Linfohistiocitosis Hemofagocítica/virología , Sepsis/mortalidad , Antibacterianos/efectos adversos , Antibacterianos/uso terapéutico , Antivirales/efectos adversos , Antivirales/uso terapéutico , Enterobacteriaceae Resistentes a los Carbapenémicos/efectos de los fármacos , Enterobacteriaceae Resistentes a los Carbapenémicos/genética , Niño , Citomegalovirus/genética , Citomegalovirus/inmunología , Infecciones por Citomegalovirus/diagnóstico , Infecciones por Citomegalovirus/tratamiento farmacológico , Infecciones por Citomegalovirus/virología , Resultado Fatal , Ganciclovir/efectos adversos , Ganciclovir/uso terapéutico , Genotipo , Humanos , Linfohistiocitosis Hemofagocítica/diagnóstico , Linfohistiocitosis Hemofagocítica/tratamiento farmacológico , Masculino , Sepsis/tratamiento farmacológico , Sepsis/microbiología , Enterococos Resistentes a la Vancomicina/efectos de los fármacos , Enterococos Resistentes a la Vancomicina/genética
18.
Clin Infect Dis ; 71(4): 1022-1029, 2020 08 14.
Artículo en Inglés | MEDLINE | ID: mdl-31617568

RESUMEN

BACKGROUND: Several countries have implemented a 2-dose (2D) human papillomavirus (HPV) vaccination schedule for adolescents based on immunobridging studies. We compared immunogenicity of 2D vs 3-dose (3D) schedules of the quadrivalent vaccine (4vHPV) up to 10 years after the first dose. METHODS: Girls aged 9-13 years were randomized to receive 2D or 3D and were compared with women aged 16-26 receiving 3D at day 1 and months 7, 24, and 120 after the first dose. Antibody levels for HPV6/11/16/18 were evaluated using the competitive Luminex immunoassay (cLIA) and total immunoglobulin G assay. Geometric mean titers (GMTs) and seropositivity rates were compared between the different groups at different time points. Noninferiority of GMT ratios was defined as the lower bound of the 2-sided 95% confidence interval (CI) being greater than 0.5. Kinetics of antibody titers over time among study groups were examined. RESULTS: At 120 months, data from 35 2D girls, 38 3D girls, and 30 3D women were used for analyses. cLIA seropositivity rates were above 95% for all HPV vaccine types and all schedules, except HPV18, with the lowest seropositivity observed among 3D women (60.0%; 95% CI, 40.6%-77.3%). GMT ratios (cLIA) for both 2D and 3D girls were noninferior to 3 doses in women for HPV6/11/16/18. Trends were comparable between assays. CONCLUSIONS: GMTs for HPV6/11/16/18 after 2D or 3D of 4vHPV in girls were noninferior to 3D in adult women up to 120 months postvaccination. This study demonstrates long-term immunogenicity of the 2D HPV vaccine schedule.


Asunto(s)
Infecciones por Papillomavirus , Vacunas contra Papillomavirus , Adolescente , Adulto , Anticuerpos Antivirales , Niño , Femenino , Estudios de Seguimiento , Vacuna Tetravalente Recombinante contra el Virus del Papiloma Humano Tipos 6, 11 , 16, 18 , Humanos , Esquemas de Inmunización , Inmunogenicidad Vacunal , Infecciones por Papillomavirus/prevención & control , Adulto Joven
19.
Vaccine ; 37(49): 7203-7206, 2019 11 20.
Artículo en Inglés | MEDLINE | ID: mdl-31648910

RESUMEN

HPV vaccines are highly immunogenic. A two-dose schedule for 9-14 year-old is recommended. However, no data exist regarding the impact of age, menarche status and body mass index (BMI) on the immune response to a two-dose schedule. In this post-hoc analysis, we present antibody titers to HPV6/11/16/18 in 9-13 year-old girls participating in a randomized clinical trial and assigned to receive two doses of quadrivalent HPV vaccine at 6 months interval (NCT00501137). Antibody titers were measured at month 7 and 24 of the study by using a competitive Luminex immunoassay (cLIA).Both, at Month 7 and 24 the GMTs for four HPV genotypes were similar across the age bands, and did not vary significantly by menarche status. Overweight and obese girls had lower GMTs. More than 99% of girls remained seropositive for HPV 6/11/16 and 89% for HPV18 at month 24. Comprehensive data in overweight and obese vaccines are warranted.


Asunto(s)
Anticuerpos Antivirales/sangre , Formación de Anticuerpos/fisiología , Vacuna Tetravalente Recombinante contra el Virus del Papiloma Humano Tipos 6, 11 , 16, 18/inmunología , Menarquia/inmunología , Infecciones por Papillomavirus/prevención & control , Adolescente , Índice de Masa Corporal , Niño , Femenino , Humanos , Esquemas de Inmunización
20.
Ann Clin Transl Neurol ; 6(2): 397-400, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30847373

RESUMEN

A 17-month-old boy from Vancouver, Canada, presented with a 5-day history of progressive somnolence, ataxia, and torticollis. Additional investigations revealed eosinophilic encephalitis with deep white matter changes on MR imaging. On day 13, serology came back positive for Baylisascaris procyonis antibodies. While prophylaxis after ingestion of soil or materials potentially contaminated with raccoon feces can prevent baylisascariasis, timely treatment can sometimes alter a disastrous outcome. Populations of infected raccoons are propagating globally, but cases of Baylisascaris neural larva migrans have so far only been reported from North America.


Asunto(s)
Infecciones por Ascaridida/patología , Infecciones Parasitarias del Sistema Nervioso Central/patología , Larva Migrans/patología , Mapaches/genética , Adolescente , Animales , Infecciones por Ascaridida/genética , Ascaridoidea/genética , Ascaridoidea/inmunología , Infecciones Parasitarias del Sistema Nervioso Central/diagnóstico , Encefalitis/genética , Encefalitis/patología , Humanos , Larva Migrans/diagnóstico , Larva Migrans/genética , Masculino , Infecciones por Nematodos/genética , América del Norte
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...